Carmen Cao

Statistics

Publications

Citations

267

H-Index

Active since

2018

Affiliations

Fundación para la Investigación, Docencia y Prevención del Cáncer(Current)

Instituto Nacional del Cáncer

Instituto de Oncología de Rosario

Centro Médico Nacional La Raza

Hospital Universitário Walter Cantídio

Carmen Cao is an author at Fundación para la Investigación, Docencia y Prevención del Cáncer specializing in hematologic malignancy therapy, hematology, and oncology.

Publications per year

2018–2019

Publications

Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymphoma: final overall survival results of a randomised, open-label, phase 3 study

Tadeusz Robak, Jie Jin, Halyna Pylypenko et al. · The Lancet Oncology · 2018 · 140 citations

Medicine, Hematology, Oncology +15

Epidemiology of Hematologic Malignancies in Real-World Settings: Findings From the Hemato-Oncology Latin America Observational Registry Study

Vânia Hungria, Carlos Chiattone, Miguel Arturo Pavlovsky et al. · Journal of Global Oncology · 2019 · 78 citations · Full text

Medicine, Hematology, Oncology +15

Multiple myeloma treatment patterns and clinical outcomes in the Latin America Haemato‐Oncology (HOLA) Observational Study, 2008–2016

Vânia Hungria, Déborah Martı́nez-Baños, Christian Omar Ramos Peñafiel et al. · British Journal of Haematology · 2019 · 49 citations · Full text

Medicine, Hematology, Oncology +16

1–3 of 3